Introduction to Selecting A Therapy For Patients With Itp And Additional Comorbidities
Welcome to our comprehensive guide on Selecting A Therapy For Patients With Itp And Additional Comorbidities. In this video, Hanny Al-Samkari, MD, Massachusetts General Hospital, Boston, MA, briefly discusses
Selecting A Therapy For Patients With Itp And Additional Comorbidities Comprehensive Overview
Physicians consider the Experts discuss the first-line James B. Bussel, MD, highlights his expectations regarding the future management of idiopathic thrombocytopenia purpura.
Ivy Altomare, MD; Keith R. McCrae, MD; and Terry Gernsheimer, MD, review clinical considerations for initiating
Summary & Highlights for Selecting A Therapy For Patients With Itp And Additional Comorbidities
- In this video, Nichola Cooper, MD, FRCP, FRCPath, Imperial College London, London, UK, provides an overview of a session ...
- Hanny Al-Samkari, MD, Massachusetts General Hospital, Boston, MA, comments on the challenges of identifying biomarkers in ...
- Ivy Altomare, MD; Terry Gernsheimer, MD; and Keith R. McCrae, MD,
- James B. Bussel, MD, describes the second-line
- James B. Bussel, MD, reviews the duration for first-line
In summary, understanding Selecting A Therapy For Patients With Itp And Additional Comorbidities gives us a better perspective.
